Abstract
Background and Objective
Behçet’s disease (BD) is a chronic inflammatory vasculitis presenting with flares and silent periods usually between 15 and 40 years of age. The aim of this study was to evaluate the possible association between Rho-kinase 1 (ROCK1) gene polymorphisms and patients with BD in a Turkish population.
Methods
A total of 192 BD patients and 255 healthy controls of similar age and sex were enrolled in this study. Polymorphisms were analyzed in genomic DNA using a BioMark HD dynamic array system.
Results
In the presence of CC genotype for rs73963110, CT genotype for rs111874856 (Val355Ile), and TC genotype for rs112130712 (Lys1054Arg) polymorphisms, the risk of BD increased 12.13-, 15.05-, and 16.28-fold, respectively (p < 0.0001). There was a lower frequency of the GA genotype of the rs112108028 (Pro1164Leu) polymorphisms in BD (10.3 %) compared with controls (39.7 %; p < 0.0001). Marked associations between these polymorphisms and the manifestations of BD were recorded.
Conclusion
This is the first study to show that ROCK1 gene polymorphisms may have a significant impact on susceptibility to BD.
Similar content being viewed by others
References
Yazici Y, Yurdakul S, Yazici H. Behçet’s syndrome. Curr Rheumatol Rep. 2010;12(6):429–35.
Haznedaroglu IC, Ozcebe OI, Ozdemir O, et al. Impaired haemostatic kinetics and endothelial function in Behçet’s disease. J Intern Med. 1996;240(4):181–7.
Kiraz S, Ertenli I, Oztürk MA, et al. Pathological haemostasis and “prothrombotic state” in Behçet’s disease. Thromb Res. 2002;105(2):125–33.
Acikgoz N, Ermiş N, Yağmur J, et al. Elevated oxidative stress markers and its relationship with endothelial dysfunction in Behçet disease. Angiology. 2011;62(4):296–300.
International Study Group for Behçet’s Disease. Criteria for diagnosis of Behçet’s disease. Lancet. 1990;335(8697):1078–80.
Keogan MT. Clinical ımmunology review series: an approach to the patient with recurrent orogenital ulceration, including Behçet’s syndrome. Clin Exp Immunol. 2009;156(1):1–11.
Mendoza-Pinto C, García-Carrasco M, Jiménez-Hernández M, et al. Etiopathogenesis of Behcet’s disease. Autoimmun Rev. 2010;9(4):241–5.
Ishizaki T, Maekawa M, Fujisawa K, et al. The small GTP-binding protein Rho binds to and activates a 160 kDa Ser/Thr protein kinase homologous to myotonic dystrophy kinase. EMBO J. 1996;15(8):1885–93.
Matsui T, Amano M, Yamamoto T, et al. Rho-associated kinase, a novel serine/threonine kinase, as a putative target for small GTP binding protein Rho. EMBO J. 1996;15(9):2208–16.
Riento K, Ridley AJ. Rocks: multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol. 2003;4(6):446–56.
Yao L, Romero MJ, Toque HA, et al. The role of RhoA/Rho kinase pathway in endothelial dysfunction. J Cardiovasc Dis Res. 2010;1(4):165–70.
Zhou Q, Gensch C, Liao JK. Rho-associated coiled-coil-forming kinases (ROCKs): potential targets for the treatment of atherosclerosis and vascular disease. Trends Pharmacol Sci. 2011;32(3):167–73.
Wojciak-Stothard B, Ridley AJ. Rho GTPases and the regulation of endothelial permeability. Vascul Pharmacol. 2002;39(4–5):187–99.
Takeda K, Ichiki T, Tokunou T, et al. Critical role of Rho-kinase and MEK/ERK pathways for angiotensin II-induced plasminogen activator inhibitor type-1 gene expression. Arterioscler Thromb Vasc Biol. 2001;21(5):868–73.
Higashi M, Shimokawa H, Hattori T, et al. Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo: effect on endothelial NAD(P)H oxidase system. Circ Res. 2003;93(8):767–75.
Ming XF, Viswambharan H, Barandier C, et al. Rho GTPase/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B/Akt in human endothelial cells. Mol Cell Biol. 2002;22(24):8467–77.
Mizuki N, Ota M, Yabuki K, et al. Localization of the pathogenic gene of Behçet’s disease by microsatellite analysis of three different populations. Invest Ophthalmol Vis Sci. 2000;41(12):3702–8.
Gül A, Hajeer AH, Worthington J, et al. Evidence for linkage of the HLA-B locus in Behçet’s disease, obtained using the transmission disequilibrium test. Arthritis Rheum. 2001;44(1):239–40.
Oguz E, Alasehirli B, Pehlivan Y, et al. Association between Rho-kinase (ROCK2) gene polymorphisms and Behçet’s disease. Transl Res. 2012;160(6):428–34.
Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215.
Karasneh J, Gül A, Ollier WE, et al. Whole-genome screening for susceptibility genes in multicase families with Behçet’s disease. Arthritis Rheum. 2005;52(6):1836–42.
Fei Y, Webb R, Cobb BL, et al. Identification of novel genetic susceptibility loci for Behçet’s disease using a genome-wide association study. Arthritis Res Ther. 2009;11(3):R66.
Remmers EF, Cosan F, Kirino Y, et al. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet’s disease. Nat Genet. 2010;42(8):698–702.
Ohno S, Ohguchi M, Hirose S, et al. Close association of HLA-Bw51 with Behçet’s disease. Arch Ophthalmol. 1982;100(9):1455–8.
Piga M, Mathieu A. Genetic susceptibility to Behcet’s disease: role of genes belonging to the MHC region. Rheumatology (Oxford). 2011;50(2):299–310.
Kaya Tİ. Genetics of Behçet’s disease. Patholog Res Int. 2012;2012:912589.
Palomino Doza J, Topf A, Bentham J, et al. Low-frequency intermediate penetrance variants in the ROCK1 gene predispose to Tetralogy of Fallot. BMC Genet. 2013;14:57.
Sari I, Berberoglu B, Ozkara E, et al. Role of rho-kinase gene polymorphisms and protein expressions in colorectal cancer development. Pathobiology. 2013;80(3):138–45.
Evereklioglu C. Current concepts in the etiology and treatment of Behçet disease. Surv Ophthalmol. 2005;50(4):297–350.
Bekpinar S, Kiliç N, Unlüçerçi Y, et al. Evaluation of nitrosative and oxidative stress in Behçet disease. J Eur Acad Dermatol Venereol. 2005;19(2):167–71.
Akcay YD, Sagin FG, Aksu K, et al. A panel of oxidative stress assays does not provide supplementary diagnostic information in Behcet’s disease patients. J Inflamm (Lond). 2012;9:13.
Onur E, Kabaroglu C, Inanir I, et al. Oxidative stress impairs endothelial nitric oxide levels in Behçet’s disease. Cutan Ocul Toxicol. 2011;30(3):217–20.
Jin L, Ying Z, Webb RC. Activation of Rho/Rho kinase signaling pathway by reactive oxygen species in rat aorta. Am J Physiol Heart Circ Physiol. 2004;287(4):H1495–500.
Kataoka C, Egashira K, Inoue S, et al. Important role of Rho-kinase in the pathogenesis of cardiovascular inflammation and remodeling induced by long-term blockade of nitric oxide synthesis in rats. Hypertension. 2002;39(2):245–50.
Shah DI, Singh M. Involvement of Rho-kinase in experimental vascular endothelial dysfunction. Mol Cell Biochem. 2006;283(1–2):191–9.
Cekmen M, Evereklioglu C, Er H, et al. Vascular endothelial growth factor levels are increased and associated with disease activity in patients with Behçet’s syndrome. Int J Dermatol. 2003;42(11):870–5.
Erdem F, Gündoğdu M, Kiki I, et al. Vascular endothelial and basic fibroblast growth factor serum levels in patients with Behçet’s disease. Rheumatol Int. 2005;25(8):599–603.
Sun H, Breslin JW, Zhu J, et al. Rho and ROCK signaling in VEGF-induced microvascular endothelial hyperpermeability. Microcirculation. 2006;13(3):237–47.
van Nieuw Amerongen GP, Koolwijk P, Versteilen A, et al. Involvement of RhoA/Rho kinase signaling in VEGF-induced endothelial cell migration and angiogenesis in vitro. Arterioscler Thromb Vasc Biol. 2003;23(2):211–7.
Zierhut M, Abu El-Asrar AM, Bodaghi B, et al. Therapy of ocular Behçet disease. Ocul Immunol Inflamm. 2014;22(1):64–76.
Dalvi SR, Yildirim R, Yazici Y. Behcet’s syndrome. Drugs. 2012;72(17):2223–41.
Rubenstein NM, Callahan JA, Lo DH, et al. Selective glucocorticoid control of Rho kinase isoforms regulate cell-cell interactions. Biochem Biophys Res Commun. 2007;354(2):603–7.
Acknowledgments
This work was financially supported by a grant (BAP TF.10.19) from the University of Gaziantep. Elif Oguz, Abdullah Tuncay Demiryürek, Yavuz Pehlivan, Bünyamin Kisacik, Esma Ozkara, Serdar Oztuzcu, Belgin Alasehirli and Ahmet Mesut Onat declare no conflicts of interest that are directly relevant to the content of this article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Oguz, E., Demiryürek, A.T., Pehlivan, Y. et al. Association of Rho-kinase 1 (ROCK1) Gene Polymorphisms with Behçet’s Disease. Mol Diagn Ther 18, 419–426 (2014). https://doi.org/10.1007/s40291-014-0092-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40291-014-0092-5